Y-Biologics Inc. announced that it will receive up to KRW 30,000,000,000 in a round of funding on February 24, 2022. The transaction will include participation from twenty-five returning investors, including DAYLI Partners Co., Ltd., DS Asset Management Co., Ltd, Smilegate Investment, Inc., Korea Omega Investment Corp, Mirae Asset Securities Co., Ltd., Kolon Investment, Inc., HK inno.N Corporation, GI Innovation, Inc., and Genexine, Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38,750 KRW | -1.27% | +2.51% | -12.82% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7,590 KRW | -1.81% | +1.34% | 2.93B | ||
7,510 KRW | +1.21% | +3.44% | 224M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.82% | 808M | |
+3.37% | 69.85B | |
+12.70% | 8.98B | |
-12.75% | 4.89B | |
+42.38% | 4.44B | |
+5.23% | 3.95B | |
+21.69% | 2.49B | |
-19.05% | 2.4B | |
-28.72% | 2.28B | |
+11.13% | 1.96B |
- Stock Market
- Equities
- A195940 Stock
- News HK inno.N Corporation
- Y-Biologics Inc. announced that it expects to receive KRW 30 billion in funding from a group of investors